jama glp-1 From JAMA: Postpartum prescription of #GLP-1RAs in Denmark increased between 2018 and 2024, with #semaglutide accounting for most prescriptions since 2023. Most users had #overweight or #obesity, and only 23% had a # GLP-1 Use Reduces Cancer Risk

Weight loss and glucose control occur because GLP-1 slows digestion, helping people feel fuller for longer periods

elegans germline contains considerable redundancy in that there are many factors that contribute to the control of this decision whose loss does not result in a severe disruption to the balance, except when in a genetic background that is sensitized to either over-proliferation or under-proliferation

Heres what theyre learning

No, most lipotropic injections are not FDA-approved

"Chuck is honest, inspiring, and deeply relatable he understands the power of GLP-1s, and needed a partner to help him stay on track with treatment," said Zach Reitano, co-founder and CEO of Ro

They all can cause significant problems with nausea too, so GLP-1 agonists are not the answer for everyone